Both in Pharmaceuticals
Immix Biopharma vs Apnimed
Over the past year IMMX returned −36.5% and APMD returned −42.6%; their daily moves had a correlation of 0.34.
IMMX −36.5% APMD −42.6%Growth of $1, one year, split-adjusted
| Metric | IMMX | APMD |
|---|---|---|
| Price | $7.71 | $15.06 |
| Market cap | $639.2M | $627.0M |
| Today | +6.20% | −2.21% |
| 1 month | −23.9% | −30.8% |
| 6 months | −19.4% | — |
| Year to date | +47.4% | — |
| 1 year | +102.9% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $232.1M | — |
| Dividend yield | — | — |
| Volatility (60d) | 69.4% | — |
| Short % of float | 22.5% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).